Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients

Mostrar otras versiones (1)

The protection afforded by vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to individuals with chronic lung disease is not well established. To understand how chronic lung disease impacts SARS-CoV-2 vaccine-elicited immunity we performed deep immunophenotyping of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haolin, Aviszus, Katja, Zelarney, Pearlanne, Liao, Shu-Yi, Gerber, Anthony N., Make, Barry, Wechsler, Michael E., Marrack, Philippa, Reinhardt, R. Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901055/
https://www.ncbi.nlm.nih.gov/pubmed/36747750
http://dx.doi.org/10.1101/2023.01.25.23284971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901055/
https://www.ncbi.nlm.nih.gov/pubmed/36747750
http://dx.doi.org/10.1101/2023.01.25.23284971

Ejemplares similares